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Background: Cerebral small vessel disease (SVD) is a common cause of stroke, mild
cognitive impairment, dementia and physical impairments. Differences in SVD incidence
or severity between males and females are unknown. We assessed sex differences in
SVD by assessing the male-to-female ratio (M:F) of recruited participants and incidence
of SVD, risk factor presence, distribution, and severity of SVD features.
Methods: We assessed four recent systematic reviews on SVD and performed a
supplementary search of MEDLINE to identify studies reporting M:F ratio in covert,
stroke, or cognitive SVD presentations (registered protocol: CRD42020193995). We
meta-analyzed differences in sex ratios across time, countries, SVD severity and
presentations, age and risk factors for SVD.
Results: Amongst 123 relevant studies (n = 36,910 participants) including 53
community-based, 67 hospital-based and three mixed studies published between 1989
and 2020, moremales were recruited in hospital-based than in community-based studies
[M:F = 1.16 (0.70) vs. M:F = 0.79 (0.35), respectively; p < 0.001]. More males had
moderate to severe SVD [M:F = 1.08 (0.81) vs. M:F = 0.82 (0.47) in healthy to mild
SVD; p < 0.001], and stroke presentations where M:F was 1.67 (0.53). M:F did not differ
for recent (2015–2020) vs. pre-2015 publications, by geographical region, or age. There
were insufficient sex-stratified data to explore M:F and risk factors for SVD.
Conclusions: Our results highlight differences in male-to-female ratios in SVD severity
and amongst those presenting with stroke that have important clinical and translational
implications. Future SVD research should report participant demographics, risk factors
and outcomes separately for males and females.
Systematic Review Registration: [PROSPERO], identifier [CRD42020193995].
Keywords: cerebral small vessel disease (SVD), sex differences, cerebral autosomal dominant arteriopathy with
subcortical infarcts and leukoencephalopathy (CADASIL), lacunar stroke, vascular dementia (VaD)
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INTRODUCTION
Cerebral small-vessel disease (SVD) is a disorder of the brain
small penetrating blood vessels leading to white and deep
gray matter damage, and is a major cause of stroke (1) and
dementia (2).
Sex differences occur in many vascular diseases (3), and
they can also be expected in the context of SVD. SVD is
most commonly sporadic, although there are rare familial types,
like cerebral autosomal dominant arteriopathy with subcortical
infarcts and leukoencephalopathy (CADASIL), which although
not sex-linked, seems to affect males more severely than females
(4). Covert SVD is common in older persons, where differences in
male:female incidence or severity have not been assessed. Several
studies of stroke of any type have recruited more males than
females and reported a higher age-adjusted incidence in males,
but higher severity in females. However, as reviewed elsewhere,
it is unclear whether these conclusions reflect underlying sex-
specific biological differences, recruitment bias, or other factors
(5). On average, females are older than males at stroke onset,
more likely to live alone and have more severe baseline deficits
(6), which could explain their increased pre-hospital delay, and
their higher severity in first-ever acute stroke (7). These factors
can affect females’ eligibility for stroke research studies, with
a bias toward recruitment of milder strokes, and for stroke
treatment, as females are less likely to be treated with IV
thrombolysis than males (8). Interestingly, females were more
likely to refuse participation in stroke clinical trials than males
independently of their age (9).
Globally, females tend to live longer than males but there is
a lack of sex and gender-stratified data in aging research (10)
that may impede more personalized care in older populations;
especially when biological factors, treatments, or social disparities
may differ between sexes (11). Understanding male:female
differences in incidence or severity of disease, particularly
of common diseases like SVD, is now a World Health
Organization imperative.
We aimed to explore if there are sex differences in covert
or clinical presentations of SVD by assessing the sex ratio
of participants with clinical or radiological evidence of SVD
recruited to a range of studies, and whether any difference could
be explained by male:female differences in risk factors or the
severity of SVD features.
METHODS
We followed the Preferred Reported Items for Systematic
Reviews and Meta-Analysis (PRISMA) guidelines and
registered the protocol on PROSPERO on July 2, 2020
(CRD42020193995) (12).
Abbreviations: CADASIL, cerebral autosomal dominant arteriopathy with
subcortical infarcts and leukoencephalopathy; CMBs, cerebral microbleeds; MRI,
magnetic resonance imaging; ICH, intracerebral hemorrhage; SVD, cerebral small
vessel disease; VaD, vascular dementia; VaCI, vascular cognitive impairment;
WMH, white matter hyperintensities.
Data Sources and Search Strategy
We identified relevant studies in two ways.
First, we examined studies that had been included in four
recent published systematic reviews of different aspects of SVD,
whose search terms were similar as for the current work, and
identified studies that met our current inclusion criteria (see
below). The four systematic reviews addressed (a) early life
risk factors for SVD (13), (b) cognitive dysfunction in SVD
(14), (c) neuropsychiatric and cognitive symptoms in SVD (15),
and (d) cerebral blood flow in SVD (16). We used the four
published systematic reviews as a highly efficient way to access
a large relevant literature, a practice which is now endorsed as
part of the drive toward reducing research waste, improving
efficiency, and best practice in evidence synthesis (17, 18). These
systematic reviews had already been thoroughly screened and
quality assessed, had each been conducted according to PRISMA
guidelines, used relevant search terms, performed study quality
assessment, had undergone peer review, and been published
(Table 1) (13–16). Each systematic review had assessed a very
large literature on a different aspect of SVD, enabling us to
assess a very large number of relevant studies as efficiently
as possible.
Second, we designed an independent search to supplement
all the studies collected from the four systematic reviews
with recent publications. We used a search strategy modified
from a published protocol (14) to identify studies including
participants with clinical (stroke or cognitive presentations) or
non-clinical presentations of sporadic or monogenic SVD (e.g.,
CADASIL). Stroke presentations included lacunar syndromes
with corresponding small subcortical infarct on neuroimaging, or
that excluded other causes of symptoms. Cognitive presentations
included vascular cognitive impairment, either vascular mild
cognitive impairment—VaMCI—or vascular dementia—VaD.
Non-clinical presentations included radiological evidence of
SVD—e.g., white matter hyperintensities (WMH), lacunes of
presumed vascular origin, small subcortical infarcts or cerebral
microbleeds (CMBs) on brain magnetic resonance imaging
(MRI) (19)—in the absence of clinical diagnosis (generally in
community-dwelling populations), i.e., “covert” SVD. We aimed
to explore trends across time by comparing recent and previously
published studies (see Results, Trends across time) and decided
to use January, 1, 2015 as the starting publication date for
recent studies. Thus, January, 1, 2015 was the first date used
for the independent search. We searched MEDLINE through
OVID for human studies published in English or Spanish from
January, 1, 2015 to May, 26, 2020 as follows: Cerebral Small
Vessel Diseases/ OR (small vessel disease or small vessel-disease
or CSVD or SVD).ti.ab. OR stroke,Lacunar/ OR [(lesion∗ or
hyperinten∗) adj3 white matter].ti.ab. OR Leukoaraiosis/ OR
lacune∗.ti.ab. OR [(lacun∗ or subcort∗ or ischemi∗ or ischaemi∗
or silent or microscopic) adj3 lesion∗).ti,ab.]. Since the used
search strategy was modified from one of these systematic
reviews’ protocol, only the most recent 150 journal articles
among the 4,871 filtered results were examined to avoid
retrieving duplicated studies that were already present in the
database. The electronic search was carried out on May, 26,
2020.
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Total number of included
participants in each review
Backhouse, 2017 Early life risk factors for cerebrovascular disease. 19,180 29 23,356
Clancy, 2020 Neuropsychiatric symptoms associated with cerebral
small vessel disease: a systematic review and
meta-analysis.
7,119 81 21,730
Hamilton, 2020 Cognitive impairment in sporadic cerebral small vessel
disease: a systematic review and meta-analysis.
8,562 69 6,908
Stewart, 2020 Associations between white matter hyperintensity
burden, cerebral blood flow and transit time in small
vessel disease: an updated meta-analysis.
783 30 3,396
Identified studies refer to those found by search after duplicates were removed. Included studies refer to those examined for data extraction. The number of included studies of each
systematic review do not include duplicated studies or populations.
Study Selection
We included cross-sectional and longitudinal studies published
in English or Spanish that considered clinical diagnosis of SVD,
radiological markers for SVD or studies reporting on patients
with stroke that provided data according to stroke subtype
(cortical or lacunar stroke). We excluded studies that did not
report proportions of males and females or stroke subtype
in the case of studies in stroke, review papers other than
the included systematic reviews, editorials, communications,
case reports, case series and conference abstracts, studies
about other neurodegenerative conditions (e.g., Parkinson’s
disease, Alzheimer’s Disease, non-vascular, or mixed dementia),
inflammatory disorders (e.g., encephalitis/meningitis/vasculitis),
single-sex populations (e.g., pregnancy studies), and genetic-
based studies that only recruited from families. To avoid possible
confounding factors related to large vessel disease, studies that
recruited participants based on cardiovascular events (e.g., heart
failure) and diffuse cardiovascular disease (e.g., atherosclerosis)
were also excluded. The population of interest was patients
presenting with stroke-related SVD (lacunar stroke), cognitive
impairment found to have radiological features of SVD on
neuroimaging, or participants with no clinical presentation
found to have radiological features of SVD on neuroimaging
(covert SVD). SVD radiological features includedWMH, lacunes,
small subcortical infarcts, CMBs, silent brain infarcts, or
prior hemorrhage.
Where more than one study presented data on the same
population, the study considering the most information about
SVD clinical diagnosis, radiological markers, or risk factors for
SVD was selected.
Data Extraction
Screening, full-text review, study selection and data extraction
were independently carried out by five authors (LJ-S, OKLH,
EVB, UC, and CRS). Studies included in the published systematic
reviews had already been assessed by two researchers. Studies
identified in the new literature search were assessed by one
researcher and cross-checked with another researcher in the case
of uncertainty about inclusion.
We extracted data on the primary author, date of publication,
country of recruited participants, study type (cross-sectional or
longitudinal), clinical or non-clinical presentation of participants
(including lacunar or subcortical stroke or hemorrhagic forms
of SVD, subjective memory or cognitive complaints, VaMCI,
VaD, or covert SVD), number of subjects, total sex ratio of
participants, mean age of participants and sex-stratifiedmean age
of participants, stratified sex ratio by clinical diagnosis of SVD,
radiological features of SVD (presence and severity of WMH,
lacunes, small subcortical infarcts, CMBs, silent brain infarcts
or prior hemorrhage) or SVD score if provided. We calculated
mean ages if not reported and data were available. Hypertension
and current or ever-smoking data were recorded if available,
since these are key modifiable risk factors known to worsen SVD
(20), and calculated sex-stratified percentages of hypertension
and smoking. An initial screening of papers indicated that there
would be few sex-stratified data to explore other risk factors. We
only extracted baseline data in longitudinal studies.
Statistical Analysis
We performed all analyses and generated plots using R (version
3.2.3) (21). We calculated sex ratios of study participants or
SVD groups of all the included studies and compared sex ratio
per type of SVD presentation. Our principal summary measure
was the median sex ratio per study setting, SVD presentation
and severity.
Since recruitment can be affected by different factors across
different settings, we classified studies into community-based,
hospital-based, or mixed (where participants were recruited
from both community and hospitals). To investigate whether
differences in sex ratios were influenced by study size, we
calculated a new variable: 1 sex ratio = |a constant of the global
population sex ratio (22) – sex ratio of each study|. We log-
transformed sizes of recruited populations due to their skewed
distribution and then assessed the correlation of 1 sex ratio with
the log-transformed size of the recruited populations per study
population type.
To explore trends across time and countries, we classified
studies by year of publication and country of recruited
participants, respectively. To explore trends across severity and
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According to the definitions used in the original articles from
which data was extracted: those defined as neurologically,
functionally or cognitively healthy, community-dwelling
individuals or participants with mild covert SVD (no clinical
presentation with radiological features of SVD originally
described as “mild”: deep or periventricular WMH, white
matter lesions, vascular white matter disease, lacunes,
leukoaraiosis, CMBs, silent brain infarcts, or ICH).
Moderate to
severe SVD
According to the definitions used in the original articles from
which data was extracted: those with moderate or severe
clinical or non-clinical presentations of SVD. This group
included stroke presentations, cognitive presentations,
moderate to severe covert SVD and genetic SVD.
Stroke
presentations
Those first presenting with a lacunar or subcortical stroke or
lacunar syndrome. Since cerebrovascular events can precede
cognitive impairment, participants with both stroke and
cognitive presentations of SVD (e.g., participants with lacunar
stroke who also presented with VaD) were considered part of




Those presenting with self-reported and/or diagnosed
cognitive impairment (subjective cognitive/memory
complaints, subjective cognitive decline, VaMCI, VaD,




Those with no clinical presentation found to have radiological
features of SVD originally described as “moderate” or
“severe” (deep or periventricular WMH, white matter lesions
vascular white matter disease, lacunes, leukoaraiosis, CMBs,
silent brain infarcts, or ICH).
Genetic SVD CADASIL
CADASIL, cerebral autosomal dominant arteriopathy with subcortical infarcts and
leukoencephalopathy; CMB, cerebral microbleeds; ICH, intracerebral hemorrhage; SVD,
cerebral small vessel disease; VaD, vascular dementia; VaMCI, vascular mild cognitive
impairment; WMH, white matter hyperintensities.
presentations of SVD, we then classified participants into healthy
to mild SVD (mild covert SVD) vs. moderate to severe SVD
(stroke presentations, cognitive presentations, moderate to severe
covert SVD and genetic SVD; detailed in Table 2).
For quantitative analyses, we used Shapiro-Wilk tests to
check for data normality. Sex ratio and sex-stratified data were
not normally distributed, so we used non-parametric statistical
tests. We used the Mann-Whitney-Wilcoxon test to explore
comparisons between two groups and the Kruskal-Wallis test
to explore comparisons between more than two groups. If the
result of the Kruskal-Wallis test was significant, we further
analyzed data by pairwise Mann-Whitney-Wilcoxon followed by
Bonferroni post-hoc correction. We assessed correlations using
Spearman’s rank correlation coefficient. In text, we present data
as median (interquartile range, IQR) with significance threshold
set at p < 0.05.
Study Quality Assessment
We performed a quality assessment of all the studies identified
through the systematic reviews and the supplementary search of
the recent literature as previously (14), rated on a scale from 0
to 8 according to STROBE guidelines, and calculated the median
and IQR of the quality score. To check sensitivity, we re-ran the
meta-analyses excluding studies with quality scores lower than
the median quality score of all included studies.
Risk of Bias Assessment
Bias refers to factors that can systematically affect the
observations and conclusions of the study, making them differ
from the truth (23). Relevant biases for this systematic review
could be explored in studies that compared SVD incidence,
severity, or risk factors in strata by sex. However, since very few
studies have been published specifically on male-to-female ratios
in SVD, and none (to our knowledge) aimed specifically to assess
male:female differences in SVD, risk of bias was not assessed in
this study.
RESULTS
We found 241 relevant journal articles in the four published
systematic reviews and the independent search. After filtering
by language, full texts of 228 publications were assessed against
inclusion/exclusion criteria (Figure 1). We extracted data and
meta-analyzed 123 studies that met the inclusion/exclusion
criteria (n = 36,910 total participants) (24–146). Two studies
included genetic SVD (CADASIL) (79, 83) and 121 studies
included sporadic SVD (characteristics of the included studies are
summarized in Supplementary Table 1). Studies were conducted
from 1989 to 2020 in 23 countries across six continents (Europe
43; Asia 39; North America 35; South America 3; Australia 2;
Africa 1).
None of the included studies reported data regarding non-
binary participants. Hence, for simplicity and without prejudice,
sex ratios are referred to as male:female ratios.
Trends Across Study Settings
Our literature search retrieved 53 community-based (n = 29,323
participants) (24–76), 67 hospital-based (n = 7,337 participants)
(77–143), and three mixed studies (n = 250 participants) (144–
146). The global sex ratio of all included studies was 0.92 (0.65).
Sex ratios differed across study setting (H = 24.35, df = 2,
p < 0.001), being greater in hospital-based studies (i.e., more
males than females) than in community-based studies: 1.16
(0.70) vs. 0.79 (0.35), respectively (pcorrected < 0.001; Figure 2A).
Considering that the mean age of the participants of the included
studies was 67, the sex ratio of community-based studies was
closer to the expected general population sex ratio (0.89 in a 70-
year old population) (22) than that of the hospital-based studies.
Sex ratio varied with study size in community-based but not
in hospital-based studies: in community-based studies, the sex
ratio was closer to that of the general population when the sample
size was larger (rhoSpearman =−0.46, p< 0.001; Figure 2B); there
was no effect of sample size on sex ratio in hospital-based studies
(rhoSpearman =−0.10; p= 0.43; Figure 2B).
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FIGURE 1 | Study selection flow diagram. AD, Alzheimer’s Disease; MCI, mild cognitive impairment.
Trends Across Time
We classified studies per year of publication into recent (from
2015 to 2020) and previously published (until and including
2014) studies.
Considering all the included studies, there were no significant
differences between sex ratios of recent studies compared with
earlier publications (U = 1,814, p = 0.75). This finding was
consistent after classifying by study type (U = 372, p = 0.58
in community-based studies; U = 551, p = 0.93 in hospital-
based studies; Figures 2C,D). Mixed studies (144–146) were not
included in this analysis since only three were retrieved by our
literature search, all published recently.
Trends Across Countries
We classified community-based and hospital-based studies by
country of recruitment (Figure 3). For clarity, studies that
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FIGURE 2 | Sex ratio of SVD studies across study setting and time. (A) Comparison of sex ratios per study type. Significant differences were found between sex
ratios of community-based (CB) and hospital-based (HB) studies (pcorrected < 0.001). (B) Correlation between the sex ratio difference and the size of the recruited
sample. 1 sex ratio = |sex ratio of general population – sex ratio of each study|. Given that the mean age of the participants of the included studies was 67, general
population sex ratio corresponds to 70-year old population (89 males per 100 females) (22). There was a negative correlation between 1 sex ratio and the size of the
population recruited in community studies (yellow, rhoSpearman = −0.46, p < 0.001) but not in hospital studies (blue, rhoSpearman = −0.10, p = 0.43). (C,D)
Comparison of sex ratios across time. No significant differences were found between sex ratios of recent studies compared with those previously published
considering all included studies (n2015−2020 = 53 vs. n1989−2014 = 67, U = 1,814, p = 0.75), (C) CB studies (n2015−2020 = 22 vs. n1989−2014 = 31, U = 372, p = 0.58)
or (D) HB studies (n2015−2020 = 31 vs. n1993−2014 = 36, U = 551, p = 0.93). ***p < 0.001.
recruited participants from more than one country (37, 63, 83,
109, 127) and mixed studies (144–146) were excluded.
Amongst community-based studies, the highest sex ratio was
found in participants recruited from the United Kingdom [1.36
(0.19), four studies, n = 893] and the lowest in participants
recruited from the Republic of Ireland (0.37, one study, n = 96;
Figure 3A). The largest recruited population came from the USA
(21 studies, n = 10,999 participants), with a median sex ratio
of 0.67 (0.36). Regarding hospital-based studies, the highest sex
ratio was found in participants recruited from Singapore (2.73,
one study, n = 97) and the lowest in participants recruited in
Brazil (0.53, one study, n = 26; Figure 3B). The largest recruited
population came from China (16 studies, n= 2,274 participants),
with a median sex ratio of 1.08 (0.48).
There were no obvious regional trends across countries for sex
ratio vs. the total number of participants for either community-
based or hospital-based studies.
Severity and Presentation of SVD
The included studies enrolled n = 25,972 healthy to mild SVD
participants (no SVD presentation or mild covert SVD, Table 2)
and n = 10,938 moderate to severe SVD participants (clinical
presentation and/or high radiological burden of SVD, Table 2).
The sex ratio was higher in healthy tomild SVD [1.08 (0.81)] than
in moderate to severe SVD [0.82 (0.47)], U = 3,031, p < 0.001
(Figure 4A).
We further classifiedmoderate to severe SVD participants into
cognitive or stroke presentations or moderate to severe covert
SVD (Table 2, Figure 4B). We excluded CADASIL studies due to
insufficient data (79, 83). Sex ratios differed significantly between
SVD presentations (H = 36.58, df = 3, p < 0.001). Participants
with stroke showed the highest sex ratio, 1.67 (0.53), compared
with healthy to mild covert SVD [0.82 (0.47), pcorrected < 0.001],
cognitive SVD [1.03 (0.91), pcorrected = 0.003], and moderate to
severe covert SVD [0.96 (0.44), pcorrected < 0.001].
Since community-based studies recruited mostly healthy
participants and presented lower sex ratios, we repeated the
severity analysis restricted to hospital-based studies (77–143),
and found similar trends. Across SVD severity, the sex ratio was
higher in moderate to severe SVD [1.26 (0.87)] than in healthy
to mild SVD [0.90 (0.58)], U = 1,240, p < 0.001. Across SVD
presentations, the sex ratio was higher in stroke presentations
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FIGURE 3 | Sex ratio of SVD studies across the world. Colored world maps representing the mean sex ratio of the total number of participants of (A)
community-based and (B) hospital-based studies. Darker shades in the color gradient correspond to higher sex ratios (i.e., more males than females). The tables on
the right specify the country of recruited participants, the number of included studies and the total population of included studies per study type. Neither multicentre
nor mixed studies were represented in these maps. AUS, Australia; BRA, Brazil; CAN, Canada; CHN, China; DEU, Germany; EGY, Egypt; ESP, Spain; FRA, France;
HKG, Hong Kong; IRL, Ireland; ISR, Israel; ITA, Italy; JPN, Japan; KOR, Korea; MEX, Mexico; NLD, The Netherlands; POL, Poland; PRT, Portugal; SGP, Singapore;
SVN, Slovenia; SWE, Sweden; TWN, Taiwan; UK, United Kingdom; USA, The United States of America.
[1.67 (0.55)] than in healthy to mild covert SVD [0.90 (0.58),
pcorrected < 0.001], cognitive SVD [1.11 (0.81), pcorrected = 0.037],
and moderate to severe covert SVD [1.13 (0.87) pcorrected = 0.02],
H= 21.82, df= 3, p < 0.001.
Age and Risk Factors for SVD
Only 10 studies (38, 64, 65, 69, 73, 81, 102, 111, 136, 143)
(2,953 participants) provided sufficient data to calculate the sex-
stratified participants’ age. There was no significant difference
in median age between total recruited males [63.78 (9.71)] and
females [64.45 (13.71), U = 49.5, p > 0.99].
Only two studies (73, 81) provided data to calculate sex-
stratified SVD risk factors (hypertension and smoking), which
were insufficient to perform further analyses.
Quality Assessment
The median study quality score was 5.5 (1). As a sensitivity
analysis, quantitative analyses were re-run excluding all studies
with a quality score < 5.5/8. All the trends observed in the total
included studies were consistent in the subset of higher-quality
studies (score ≥ 5.5/8; Supplementary Table 2).
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FIGURE 4 | Sex ratio across SVD severity and presentation. Sex ratio of healthy to mild SVD compared with (A) moderate to severe SVD and (B) stratified moderate
to severe SVD. Significant differences were found between SVD severity groups i.e., sex ratios of healthy to mild SVD and moderate to severe SVD (A; U = 3,031,
p < 0.001). Significant differences were also found between SVD presentation groups (H = 36.58, df = 3, p < 0.001) i.e., stroke presentations of SVD compared with
healthy to mild covert SVD, moderate to severe covert SVD or cognitive SVD (B; pcorrected < 0.001, pcorrected < 0.001, pcorrected = 0.003, respectively). **p < 0.01,
***p < 0.001.
DISCUSSION
This meta-analysis of 123 studies (24–146) including 36,910
participants demonstrates sex differences in SVD across study
settings, by SVD severity and presentation. A greater male-to-
female ratio was found in hospital-based (77–143) compared to
community-based studies (24–76) (Figure 2), and in moderate
to severe SVD, particularly in stroke presentations (Figure 4).
The pattern was consistent across recent (2015–2020) and
previous (1989–2014) studies (Figures 2C,D), and world regions
(Figure 3). To the best of our knowledge, this is the first
systematic review and meta-analysis to explore sex differences in
SVD and has important implications. The apparent presence of
more severe SVD inmales, particularly amongst those presenting
with stroke, may indicate differences in risk factor exposures,
susceptibility to SVD, adherence to risk factor interventions, or
differences in study recruitment. Awareness of these differences,
which were robust to study location and population, may
help inform approaches to mitigate the long-term effects of
covert SVD and for secondary prevention of SVD-related stroke.
Unfortunately, very few studies reported risk factor differences
between males and females and even age was not commonly
reported. Furthermore, future studies should report male and
female demographics, risk factors and outcomes, not just total
sample data.
The different sex ratios between community-based and
hospital-based studies may reflect differences in recruitment
in these settings. Typically, females are older and have more
disability at stroke onset (7), which may affect study eligibility.
For example, ischemic stroke patients older than 80 years
have higher rates of disability following thrombolysis treatment
(147) and are less likely to be recruited into stroke trials
(148). Furthermore, women with stroke may present with
non-traditional symptoms like altered mental status (149),
which could be overlooked or misdiagnosed (150, 151), and
are important since atypical and neuropsychiatric symptoms
are increasingly recognized to associate with SVD (15). Sex
differences in clinical presentations are also present in dementia
(152) but none of the included studies reported these in VaCI
or VaD. Moreover, informal carers of dependent persons in the
UK are more likely to be middle-aged women with multiple
roles until later life (70+) (153). Thus, females may be reluctant
to participate in studies due to care responsibilities or may
normalize their early symptoms while providing care. Caregiving
roles vary by country (154), socioeconomic status and culture
of care (155), which might explain why more females seemed to
participate in Chinese hospital-based studies compared with the
UK or Canada (Figure 3B) since Chinese males are traditionally
the predominant caregivers for older parents (156). Some of the
aforementioned factors that may alter female recruitment to SVD
studies have recently been highlighted as contributors to lower
enrolment of women in stroke clinical trials more generally (157).
It could also be that SVD is more prevalent and/or severe
in males than in females, increasing the likelihood of males
becoming participants in studies investigating severe SVD. In
support of this, male-sex was an independent predictor of
severity of SVD in an adjusted analysis, albeit in a 62% male
population (20). Similarly, a greater prevalence of stroke, higher
cognitive impairment and cerebral atrophy have been reported in
men with CADASIL (158). Sex differences can be driven by sex-
specific biological factors e.g., sexual dimorphism in endothelial
function (159). In premenopausal females, oestrogens enhance
endothelial production of vasodilator factors (160). This may
explain young males having greater vasoconstrictor tone
compared to pre-menopausal females (159) and male endothelial
function becoming suboptimal under certain insults. We found
no differences in age between recruited males and females,
although fewer data were available for this analysis. Different
lifestyle-related risk factors could also contribute to the sex-
specific severity of SVD, e.g., utilization of preventative health
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care services, smoking, or hypertension. Interestingly, the
prevalence of smoking and hypertension is higher among males
in most countries (161, 162), varying with ethnicity (163).
Unfortunately, there were insufficient data to determine if sex-
specific risk factor effects were driving the sex ratio difference in
SVD severity and presentation.
The unequal sex ratios found here may be explained by
factors with different contributions across different settings,
evidenced by the different effect of study size on sex ratio within
community-based and hospital-based studies (Figure 2B), or in
the context of higher SVD severity and stroke presentations. The
lack of difference between sex ratios of recent and earlier studies
(Figures 2C,D) suggests that the same factors may have operated
long term.
The implications for future research and clinical practice are
varied and important. The lack of sex-stratified data, previously
reported in brain structural studies (164) and aging research
(10), hampers translational research and personalized care.
Results should be reported and analyzed by sex, especially when
biological factors, treatments or social disparities may differ
between sexes (11). This was addressed recently (165, 166) in
support of the Sex and Gender Equity in Research (SAGER)
guidelines (167) and the European Commission second report
on Gendered Innovations (168), which provides guidance for
researchers to incorporate sex, gender and intersectional analysis
across several research topics. Future studies should also identify
and try to avoid recruitment bias, explore whether SVD is
more frequently underestimated or misdiagnosed in females and
investigate reasons why males may be more severely affected.
Larger sample sizes may help to reduce sampling variability
at least within community-based studies with a majority of
functionally healthy individuals (Figure 2B). If the disease in
females is going unrecognized, doctors and the public could be
educated to better recognize atypical symptoms in females. If
males are more severely affected or exposed to certain lifestyle
factors, trials may need to target drivers of males’ vulnerability
and health promotion campaigns could be designed to have more
impact on males.
This study had limitations. First, it was not possible to explore
common risk factors of SVD due to the scarcity of sex-stratified
data. Also, other risk factors and their differences between sexes
were not explored (e.g., lower educational attainment, associated
with increased risk of SVD in later life) (13). Most studies are
from industrialized countries (Figure 3), so our results might
not fully represent other populations. Since this study relied
on studies’ own criteria for SVD severity, future explorations
could investigate heterogeneity in study criteria and attempt
further standardization efforts. Future work could also explore
the sex-stratified functional status of participants, which may
affect eligibility criteria and result in exclusion of females who
are more functionally disabled (6, 8, 169).
The study also has strengths. We included studies from four
recent systematic reviews, which covered different aspects of SVD
(and therefore likely different literatures), each had assessed a
large literature, and the source files were immediately available to
us. We did not use our older systematic reviews as the included
literature would not have been so up to date or comprehensive.
We hope that our approach might encourage other groups to
evaluate their high-quality systematic reviews in the same way. A
broad approach was taken to capture changes across time, study
settings, different cultural or ethnic groups, SVD severity and
presentation. The included studies were conducted from 1989 to
2020, recruited 36,910 participants from the community and/or
hospitals in 23 countries across six continents, and explored a
wide range of SVD radiological features and presentations. Our
results highlight sex-specific variability in study participation,
SVD severity, and presentation. These findings are relevant for
future research and clinical practice, but much more work is
needed to unmask sex-specific biological and social disparities
and disentangle their contributions to sex differences in SVD.
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